Detalhe da pesquisa
1.
Analyses and Correlation of Pathologic and Ocular Cutaneous Changes in Murine Graft versus Host Disease.
Int J Mol Sci
; 23(1)2021 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008621
2.
Very Low Numbers of CD4+ FoxP3+ Tregs Expanded in Donors via TL1A-Ig and Low-Dose IL-2 Exhibit a Distinct Activation/Functional Profile and Suppress GVHD in a Preclinical Model.
Biol Blood Marrow Transplant
; 24(9): 1788-1794, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29751114
3.
Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 23(5): 757-766, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28219835
4.
Novel Scoring Criteria for the Evaluation of Ocular Graft-versus-Host Disease in a Preclinical Allogeneic Hematopoietic Stem Cell Transplantation Animal Model.
Biol Blood Marrow Transplant
; 22(10): 1765-1772, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27492793
5.
Use of Post-transplant Cyclophosphamide Treatment to Build a Tolerance Platform to Prevent Liquid and Solid Organ Allograft Rejection.
Front Immunol
; 12: 636789, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33737937
6.
STING differentially regulates experimental GVHD mediated by CD8 versus CD4 T cell subsets.
Sci Transl Med
; 12(552)2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32669421
7.
Superior immune reconstitution using Treg-expanded donor cells versus PTCy treatment in preclinical HSCT models.
JCI Insight
; 3(20)2018 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30333311
8.
BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
Front Immunol
; 9: 3104, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30733722